Healthcare provider profile · identity verified

Allyssa Vendiola Perez

Nurse Practitioner · MOUNT HOLLY, NJ · NPI 1679926539

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	360	130
Amlodipine Besylate	Amlodipine Besylate	214	90
Furosemide	Furosemide	190	80
Pantoprazole Sodium	Pantoprazole Sodium	184	73
Gabapentin	Gabapentin	179	67
Lisinopril	Lisinopril	167	68
Clopidogrel	Clopidogrel Bisulfate	152	45
Metoprolol Tartrate	Metoprolol Tartrate	145	62
Levothyroxine Sodium	Levothyroxine Sodium	143	67
Eliquis	Apixaban	130	55
Metformin Hcl	Metformin Hcl	123	48
Metoprolol Succinate	Metoprolol Succinate	117	54
Tamsulosin Hcl	Tamsulosin Hcl	112	40
Losartan Potassium	Losartan Potassium	109	43
Trazodone Hcl	Trazodone Hcl	94	39
Carvedilol	Carvedilol	86	33
Escitalopram Oxalate	Escitalopram Oxalate	85	39
Sertraline Hcl	Sertraline Hcl	83	31
Potassium Chloride	Potassium Chloride	76	37
Duloxetine Hcl	Duloxetine Hcl	74	23
Nystatin	Nystatin	73	34
Albuterol Sulfate Hfa	Albuterol Sulfate	71	36
Hydralazine Hcl	Hydralazine Hcl	67	24
Montelukast Sodium	Montelukast Sodium	63	23
Alprazolam	Alprazolam	59	27
Simvastatin	Simvastatin	59	30
Mirtazapine	Mirtazapine	57	30
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	20
Omeprazole	Omeprazole	55	28
Rosuvastatin Calcium	Rosuvastatin Calcium	55	24
Allopurinol	Allopurinol	53	18
Hydrochlorothiazide	Hydrochlorothiazide	53	17
Lorazepam	Lorazepam	51	20
Quetiapine Fumarate	Quetiapine Fumarate	47	27
Januvia	Sitagliptin Phosphate	44	15
Fluticasone Propionate	Fluticasone Propionate	43	25
Famotidine	Famotidine	37	17
Tramadol Hcl	Tramadol Hcl	36	22
Clonazepam	Clonazepam	35	14
Azithromycin	Azithromycin	34	33
Baclofen	Baclofen	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	18
Pregabalin	Pregabalin	33	14
Pravastatin Sodium	Pravastatin Sodium	32	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	12
Hydrocortisone	Hydrocortisone	31	suppressed
Levetiracetam	Levetiracetam	31	15
Donepezil Hcl	Donepezil Hcl	30	17
Memantine Hcl	Memantine Hcl	30	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Glipizide	Glipizide	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	14
Klayesta	Nystatin	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	22
Nyamyc	Nystatin	26	15
Atenolol	Atenolol	25	suppressed
Mupirocin	Mupirocin	25	11
Nifedipine Er	Nifedipine	25	suppressed
Spironolactone	Spironolactone	25	12
Latanoprost	Latanoprost	24	14
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Ibuprofen	Ibuprofen	23	13
Nystop	Nystatin	23	11
Finasteride	Finasteride	22	11
Meloxicam	Meloxicam	22	13
Telmisartan	Telmisartan	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Glipizide Er	Glipizide	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	17
Enalapril Maleate	Enalapril Maleate	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Methimazole	Methimazole	18	suppressed
Midodrine Hcl	Midodrine Hcl	18	11
Risperidone	Risperidone	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Cephalexin	Cephalexin	17	16
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	17
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Prednisone	Prednisone	16	13
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Lactulose	Lactulose	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Glimepiride	Glimepiride	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Phenobarbital	Phenobarbital	14	suppressed
Clotrimazole	Clotrimazole	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Levofloxacin	Levofloxacin	13	12
Temazepam	Temazepam	13	suppressed
Cefuroxime	Cefuroxime Axetil	12	12
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Valsartan	Valsartan	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error